Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Bezan, A; Gerger, A; Pichler, M.
MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Anticancer Res. 2014; 34(6):2709-2713
Web of Science PubMed

 

Autor/innen der Med Uni Graz:
Gerger Armin
Pichler Martin
Terbuch Angelika
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
Testicular germ cell tumors (TGCTs) represent the most common type of solid tumors among men aged 15 to 40 years. An increasing incidence has been recorded in developed countries. In clinical practice, TGCTs are classified as seminomas and non-seminomatous tumors. Non-seminomatous tumors often contain multiple different cell types and can be further sub-divided according to the histological and cellular phenotype in embryonal carcinomas, choriocarcinomas, yolk sac tumors and teratomas. For the clinical management of TGCTs, blood-based markers such as lactate dehydrogenase, alpha-fetoprotein and human chorionic gonadotropin are essential tools for diagnosis, risk assessment and patient's prognosis. However, only 60% of patients with TGCTs show increased serum levels of these tumor markers. This proportion of patients is even lower for those with seminomas or pure embryonal carcinomas as alpha-fetoprotein is predominantly related to yolk sac tumor and human chorionic gonadotropin to choriocarcinoma. Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
Find related publications in this database (using NLM MeSH Indexing)
Biomarkers, Tumor - blood
Humans -
Male -
MicroRNAs - genetics
Prognosis -
Testicular Neoplasms - diagnosis
Testicular Neoplasms - etiology
Testicular Neoplasms - therapy

Find related publications in this database (Keywords)
Testicular cancer
microRNAs
pathophysiology
diagnosis
prognosis
review
© Med Uni Graz Impressum